Camena Bioscience, a synthetic biology company providing genes to the pharmaceutical and biotechnology industries, has closed a $10m Series A financing round led by Mercia, which will be used to scale operations and continue development of its DNA synthesis platform, gSynth™ . Click to read more.
15 June 2023 NORTHERN 3 VCT PLC ANNUAL FINANCIAL REPORT FOR THE YEAR ENDED 31 MARCH 2023 Northern 3 VCT PLC is a Venture Capital Trust managed by Mercia Fund Management Limited. It invests. | June 15, 2023
A Yorkshire data consultancy that has more than doubled in size in the past two years has raised £500,000 from NPIF - Mercia Debt Finance, which is managed by Mercia and is part of the. | June 9, 2023
Mercia Asset Management PLC - Warwickshire, England-based specialist asset manager - Says Warwick Acoustics Ltd has secured its first production contract with a global top ten luxury [vehicle]. | June 7, 2023